From: Fatigue, stigma, and mood in patients with multiple sclerosis: effectiveness of guided imagery
Variable | Control N) %) | Intervention N) %) | Statistic | p | |
---|---|---|---|---|---|
Gender | Male | 4 (13.3) | 3 (10) | 0.99 | |
Female | 26 (86.7) | 27 (90) | |||
Marital status | Single | 4 (13.3) | 5 (17.6) | 0.99 | |
Married | 22 (73.3) | 32 (73.3) | |||
Other | 4(13.3) | 3 (10) | |||
Education level | High school | 15 (50) | 13 (43.3) | χ2 = 0.26 | 0.60 |
Abovediploma | 15 (50) | 17 (56.7) | |||
Job | Employed | 13 (43.3) | 12 (40) | 0.40 | |
housewife | 16 (53.3) | 14(46.7) | |||
Student | 0 (0) | 3 (10) | |||
Unemployed | 1 (3.3) | 1 (3.3) | |||
Type of disease | Recurrent and receding | 23(76.7) | 25(83.3) | χ2 = 0.41 | 0.51 |
Progressive recurrent | 7(23.3) | 5(16.7) | |||
Early Progressive | |||||
Secondary progressive | 6(20) | ||||
monthly income | One million and less | 5(16.7) | 17(56.7) | χ2 = 0.15 | 0.92 |
Between one and three million | 17(57.7) | 7(23.3) | |||
Between three and five million | 8(26.7) | ||||
Time of onset of the disease | One to five years | 11(36.7) | 8(26.7) | χ2 = 0.69 | 0.70 |
Five to ten years | 11(36.7) | 9(30) | |||
Ten years and older | 8(28.7) | 28(93.3) | |||
Recurrence in One year ago | Once or twice | 26(86.7) | 2(13.3) | 0.67 | |
More than twice | 4(6/7) | 8(26.7) | |||
Type of drug used | Interferon beta | 13(43.3) | 4(13.3) | 0.21 | |
Glatiramer acetate | 1(3.3) | 3(10) | |||
Fingolimod | 5(16.7) | 3(10) | |||
Rituxymab | 1(3.3) | 8(26.7) | |||
Diphosel | 5(16.7) | 0(0) | |||
Other | 3(10) | 4(13.3) | |||
None | 2(6.7) | 0(0) | |||
drug use | Yes | 0(0) | 30(100) | ||
No | 30(100) | 4(13.3) | |||
Family history | Yes | 9(30) | 26(86.7) | χ2 = 2.45 | 0.21 |
No | 21(70) | ||||
Age | M±SD (39.73±9.45) | M±SD (38.40±10.29) | t=0.52 | 0.6 |